Table 2.
Primary and Secondary Outcomes from Individual Studies
| Study (first author, year) | Primary outcomes | Secondary outcome | ||||||
|---|---|---|---|---|---|---|---|---|
| Operation duration (mins) | Intraoperative blood loss (mL) | Fluoroscopy use (times used, n) | AOFAS score | |||||
| 3D | Control | 3D | Control | 3D | Control | 3D | Control | |
| Yang, 2016 | 71 ± 23 | 98 ± 20 | 65 ± 26 | 90 ± 38 | n/s | n/s | n/s | n/s |
| Zheng, 2017 | 71.4 ± 6.8 | 91.3 ± 11.2 | 226.1 ± 22.6 | 288.7 ± 34.8 | 5.6 ± 1.9 | 8.6 ± 2.7 | 87.6 ± 7.6 | 85.8 ± 9.0 |
| Zheng, 2018 | 74.1 ± 8.2 | 90.2 ± 10.9 | 117.1 ± 20.7 | 159.8 ± 26.5 | 7.6 ± 2.2 | 11.0 ± 2.9 | 87.4 ± 8.7 | 84.7 ± 9.0 |
| Ozturk, 2020 | 83.3 ± 4.6 | 130.0 ± 5.8 | 83.6 ± 4.6 | 105.1 ± 5.6 | 6.8 ± 1.4 | 11.7 ± 1.5 | 86.1 ± 4.1 | 84.5 ± 4.9 |
| Dai, 2021 | 46.7 ± 7.2 | 55.1 ± 8.8 | 14.3 ± 5.7 | 18.7 ± 6.0 | 9.5 ± 1.8 | 11.2 ± 1.8 | 90.4 ± 5.3 | 87.7 ± 6.4 |
Primary outcomes include operation duration, intraoperative blood loss and fluoroscopy use. AOFAS score was used as a secondary outcome. n/s not stated